Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 291 to 300 of 359 resources

  • Shooting Up: Infections among people who inject drugs in the UK 2012: An update November 2013
    A Public Health England update on the 2012 report, looking at changing patterns of injecting drug use in England; injection of image and performance enhancing drugs; changing patterns of psychoactive drug injection; and providing an update on infections and behaviours, as well as making recommendations.
    England Nov 2013 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK 2014 - An update, November 2015
    This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014. Among its findings are that:

    - Two in five of those people in the UK who inject psychoactive drugs are living with hepatitis C, with around half of these infections remaining undiagnosed.
    - Changing patterns of psychoactive drug injection are increasing the risk of infection.
    UK, England, Northern Ireland, Scotland, Wales Nov 2015 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK, 2016
    This resource, produced by Public Health England, provides an annual update on infections among people who inject drugs (PWIDs) in the UK. The report reveals that hepatitis C remains the most common blood-borne infection among PWIDs, and that approximately half (48%) of hepatitis C infections among PWIDs remain undiagnosed. Of those who were unaware of their infection, 22% reported that they had never been tested, and of those unaware but tested, 44% reported that their last test had been more than two years earlier.
    UK Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK, 2018
    This December 2019 update to the Shooting Up: Infections among people who inject drugs in the UK, produced by Public Health England, provides updated data to the end of 2018. The report says that there is early evidence for a reduction in chronic hepatitis C prevalence among injecting drug users, but that rates of new infection are unchanged, including amongst individuals who have recently started injecting.
    UK 20 Dec 2019 Reports & Research PDF
  • Signposting the Way to Elimination by 2025
    The Hepatitis C Coalition is an umbrella group of leading clinicians, patient organisations, professional groups, industry and other interested parties committed to the reduction of morbidity and mortality associated with hepatitis C and its eventual elimination. This collaborative strategy builds on the release of the All-Party Parliamentary Group on Liver Health's 'Eliminating Hepatitis C in England' report and Public Health England's 'Hepatitis C in England: 2018 Report', with the aim of coordinating action by the key stakeholders involved in delivering elimination.
    England Reports & Research, Strategy & Planning PDF
  • Social Impact of HCV
    This presentation from Dr Rui Tato Marinho, Gastroenterologist at Lisbon Medical School, was first delivered at the 'HCV and Your Body' conference in Amsterdam in November 2014. It provides an overview of the physical, mental and social impact of hepatitis C, and covers issues such as stigma; homelessness; unemployment and loss of productivity.
    UK, Rest of World Nov 2014 Other, Reports & Research PDF
  • Standards for Local Surveillance and Follow Up of Hepatitis B and C
    These standards, produced by the Health Protection Agency in 2011, recognise that the detection and clinical management of hepatitis B and C can involve a number of health professionals, creating a diversity of clinical pathways. The development of the standards has also taken into account the fact that the prevalence of both hepatitis B and C varies markedly across the country and that current systems for the surveillance and follow up of cases also vary.
    UK 2011 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Staying Alive in Scotland: Strategies to Prevent Drug Deaths
    This updated toolkit, a partnership between the Scottish Government and Scottish Drugs Forum, updates the original report produced three years ago. The resource notes that DAA treatments for hepatitis C provide an opportunity to prevent drug-related deaths, but that opportunities to test for hepatitis C are being missed.
    Scotland 20 Dec 2019 Reports & Research PDF
  • Steve Callaghan: HCV Action Commissioning Toolkit

    Steve Callaghan, who co-led development of the HCV Action Commissioning Toolkit, introduces the resource for commissioners of hepatitis C. The toolkit explains why effective commissioning for hepatitis C is essential, and gives advice on commissioning for outcomes under the new NHS by effectively assessing need, gathering evidence, developing services and measuring results. 

    UK Case study Video
  • Summary report: Bristol & Severn ODN workshop, Bristol
    This report provides a summary of the Bristol & Severn ODN Workshop held by HCV Action, in partnership with the ODN, in Bristol on 14th September 2017. The workshop brought together a range of stakeholders working across the hepatitis C pathway in the Bristol & Severn ODN region, with the aim of discussing some of the barriers faced by the ODN, as well as providing a forum in which to develop solutions to some of these challenges. The report includes summaries of the day's talks and group discussion, as well as suggested next steps to be taken following the event.
    South West Reports & Research PDF